Brian Lin, PhD, discussed the current evidence linking football participation with ALS, the questions that remain unanswered, and how emerging research may help clarify the association.
|Videos|April 5, 2021
AUPN Leadership Minute Episode 8: Engaging Medical Students in Neurology – Part 1
Author(s)Rohit Das, MD, Robert M. Pascuzzi, MD
Episode 8 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Robert M. Pascuzzi, MD, of Indiana University School of Medicine. [WATCH TIME: 4 minutes]
Advertisement
WATCH TIME: 4 minutes
AUPN's Leadership Minute is a brief, highly focused summary of practical advice for Chairs, Program Directors and other leaders in academic neurology, available as both mini-podcasts and in short form videos.
The goal of this program is to provide relevant and useful information in a modicum of time, designed to fit seamlessly into our very busy schedules.
Early involvement
- Neurology is inherently interesting.
- The clinical faculty is involved with every layer of the curriculum from the basic (foundational) sciences to the clinical rotations.
- The best clinicians and teachers should be involved with basic neuroanatomy, neurophysiology, etc,
The Clerkship
- Most schools have a dedicated clinical clerkship/rotation. For those that don’t it is essential to create one, and education leadership in neurology can effectively advocate for those departments.
- Most clerkships are in the 3rd year. But some are placed in the 4th year which is too late for most students to change their career trajectory.
- If a department needs help in resolving the scheduling issue with their school, education leadership from our professional organizations can provide strong and convincing support.
Advertisement
Related to this article
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Jennifer Fokas, MD, and Minali Nigam, MD. [LISTEN TIME: 21 minutes]
Robert Bowser, PhD, chief scientific officer at Barrow Neurological Institute, recaps his ALS Nexus presentation on TDP-43 biology, the emerging therapeutic landscape, and how cryptic peptide biomarkers could reshape ALS clinical trial design.
KuangHua Guo, MD, PhD, sleep specialist at Northwestern Medicine, discussed emerging orexin agonist therapies and refined diagnostic approaches for hypersomnia.
The FDA has granted Scholar Rock's apitegromab fast track designation for the treatment of patients with living facioscapulohumeral muscular dystrophy as the company's phase 2 FORGE study dosing begins.
Tonic motor activation therapy was associated with reductions in RLS severity, along with tolerable reductions in dopamine agonist dosing, in adults with medication-refractory RLS.
A migraine forecasting model achieved 91% precision using app data, but the study did not test whether next-day predictions improve care.
The professor of neurology at the University of Cincinnati discussed why disparities persist in secondary stroke prevention and how growing awareness of social determinants of health is helping to close the gap for underserved patients.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Ulefnersen Meets Primary End Point in Phase 3 FUSION Trial for FUS-ALS
2
From Biomarkers to Prevention: Key Alzheimer Research Stories of 2026
3
Qihuang Needle Acupuncture Improves Motor and Nonmotor Parkinson Disease Symptoms
4
FDA Grants Fast Track Designation to Apitegromab for Facioscapulohumeral Muscular Dystrophy
5